344 related articles for article (PubMed ID: 24365858)
1. Postoperative polymyxin B hemoperfusion and mortality in patients with abdominal septic shock: a propensity-matched analysis.
Iwagami M; Yasunaga H; Doi K; Horiguchi H; Fushimi K; Matsubara T; Yahagi N; Noiri E
Crit Care Med; 2014 May; 42(5):1187-93. PubMed ID: 24365858
[TBL] [Abstract][Full Text] [Related]
2. Is postoperative polymyxin B hemoperfusion for abdominal septic shock really ineffective?
Hashiguchi N; Iba T
Crit Care Med; 2014 Aug; 42(8):e596-7. PubMed ID: 27069987
[No Abstract] [Full Text] [Related]
3. Is postoperative polymyxin B hemoperfusion for abdominal septic shock really ineffective?
Hashiguchi N; Iba T
Crit Care Med; 2014 Aug; 42(8):e596-7. PubMed ID: 25029151
[No Abstract] [Full Text] [Related]
4. Direct hemoperfusion with a polymyxin B column versus vasopressin for gram negative septic shock: a matched cohort study of the effect on survival.
Sawa N; Ubara Y; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hoshino J; Suwabe T; Uchida N; Wake A; Taniguchi S; Takaichi K
Clin Nephrol; 2013 Jun; 79(6):463-70. PubMed ID: 23253903
[TBL] [Abstract][Full Text] [Related]
5. Polymyxin B hemoperfusion: matching the cure to the disease.
Cruz DN
Crit Care Med; 2014 May; 42(5):1309-10. PubMed ID: 24736351
[No Abstract] [Full Text] [Related]
6. Potential Survival Benefit of Polymyxin B Hemoperfusion in Septic Shock Patients on Continuous Renal Replacement Therapy: A Propensity-Matched Analysis.
Iwagami M; Yasunaga H; Noiri E; Horiguchi H; Fushimi K; Matsubara T; Yahagi N; Nangaku M; Doi K
Blood Purif; 2016; 42(1):9-17. PubMed ID: 26918904
[TBL] [Abstract][Full Text] [Related]
7. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.
Cruz DN; Antonelli M; Fumagalli R; Foltran F; Brienza N; Donati A; Malcangi V; Petrini F; Volta G; Bobbio Pallavicini FM; Rottoli F; Giunta F; Ronco C
JAMA; 2009 Jun; 301(23):2445-52. PubMed ID: 19531784
[TBL] [Abstract][Full Text] [Related]
8. The authors reply.
Iwagami M; Yasunaga H; Doi K; Noiri E
Crit Care Med; 2014 Aug; 42(8):e597-8. PubMed ID: 25674634
[No Abstract] [Full Text] [Related]
9. The authors reply.
Iwagami M; Yasunaga H; Doi K; Noiri E
Crit Care Med; 2014 Aug; 42(8):e597-8. PubMed ID: 25029152
[No Abstract] [Full Text] [Related]
10. Effects of Polymyxin B Hemoperfusion on Septic Shock Patients Requiring Noradrenaline: Analysis of a Nationwide Administrative Database in Japan.
Fujimori K; Tarasawa K; Fushimi K
Blood Purif; 2021; 50(4-5):560-565. PubMed ID: 33582663
[TBL] [Abstract][Full Text] [Related]
11. Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study.
Nakamura Y; Kitamura T; Kiyomi F; Hayakawa M; Hoshino K; Kawano Y; Yamasaki R; Nishida T; Mizunuma M; Ishikura H;
Crit Care; 2017 Jun; 21(1):134. PubMed ID: 28592318
[TBL] [Abstract][Full Text] [Related]
12. Polymyxin B-immobilized fiber hemoperfusion after emergency surgery in patients with chronic renal failure.
Tojimbara T; Sato S; Nakajima I; Fuchinoue S; Akiba T; Teraoka S
Ther Apher Dial; 2004 Aug; 8(4):286-92. PubMed ID: 15274679
[TBL] [Abstract][Full Text] [Related]
13. Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis.
Chang T; Tu YK; Lee CT; Chao A; Huang CH; Wang MJ; Yeh YC
Crit Care Med; 2017 Aug; 45(8):e858-e864. PubMed ID: 28445237
[TBL] [Abstract][Full Text] [Related]
14. Direct hemoperfusion with polymyxin B-immobilized cartridge in severe sepsis due to intestinal perforation: hemodynamic findings and clinical considerations in anticoagulation therapy.
Maynar J; Martínez-Sagasti F; Herrera-Gutiérrez M; Martí F; Candel FJ; Belda J; Castaño S; Sanchez-Izquierdo JÁ
Rev Esp Quimioter; 2013 Jun; 26(2):151-8. PubMed ID: 23817653
[TBL] [Abstract][Full Text] [Related]
15. Rescue therapy with polymyxin B hemoperfusion in high-dose vasopressor therapy refractory septic shock.
Monti G; Terzi V; Calini A; Di Marco F; Cruz D; Pulici M; Brioschi P; Vesconi S; Fumagalli R; Casella G
Minerva Anestesiol; 2015 May; 81(5):516-25. PubMed ID: 25319136
[TBL] [Abstract][Full Text] [Related]
16. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial.
Klein DJ; Foster D; Walker PM; Bagshaw SM; Mekonnen H; Antonelli M
Intensive Care Med; 2018 Dec; 44(12):2205-2212. PubMed ID: 30470853
[TBL] [Abstract][Full Text] [Related]
17. Effects of polymyxin B hemoperfusion on hemodynamics and prognosis in septic shock patients.
Lee CT; Tu YK; Yeh YC; Chang T; Shih PY; Chao A; Huang HH; Cheng YJ; Yeh YC;
J Crit Care; 2018 Feb; 43():202-206. PubMed ID: 28915395
[TBL] [Abstract][Full Text] [Related]
18. Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial.
Dellinger RP; Bagshaw SM; Antonelli M; Foster DM; Klein DJ; Marshall JC; Palevsky PM; Weisberg LS; Schorr CA; Trzeciak S; Walker PM;
JAMA; 2018 Oct; 320(14):1455-1463. PubMed ID: 30304428
[TBL] [Abstract][Full Text] [Related]
19. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial.
Payen DM; Guilhot J; Launey Y; Lukaszewicz AC; Kaaki M; Veber B; Pottecher J; Joannes-Boyau O; Martin-Lefevre L; Jabaudon M; Mimoz O; Coudroy R; Ferrandière M; Kipnis E; Vela C; Chevallier S; Mallat J; Robert R;
Intensive Care Med; 2015 Jun; 41(6):975-84. PubMed ID: 25862039
[TBL] [Abstract][Full Text] [Related]
20. Impact of prothrombin time-International Normalized Ratio on outcome of patients with septic shock receiving polymyxin B cartridge hemoperfusion.
Ishizuka M; Tago K; Kubota K
Surgery; 2014 Jul; 156(1):168-75. PubMed ID: 24929766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
